611 W. Union Street
Benson, AZ 85602
(520) 586-0800

Health Choice Integrated Care crisis Line
1-877-756-4090

NurseWise 24-Hour Crisis Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530



SEABHS
611 W. Union Street
Benson, AZ 85602
(520) 586-0800

NurseWise 24-Hr Crisis Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530


powered by centersite dot net

Getting Started
Here are some forms to get started. These can be printed and brought with you so that you can pre-fill out some known info ahead of time. More...


Medical Disorders
Resources
Basic InformationLookupsLatest News
USPSTF: Evidence Lacking for Nontraditional CVD Risk FactorsRising BMI Has Slowed Improvement in U.S. MortalityIs Obesity Slowing Gains in U.S. Life Spans?Hold That Sneeze? Maybe NotSauna Sessions May Be as Good as Exercise for the HeartFor Kids, Chronic Illness May Trigger Mental Health IssuesWildfires Can Affect Air Quality Far From the FlamesConsiderable Economic Burden for Asthma in United StatesDuration of Diabetes, Prediabetes Linked to Presence of CACYour Dishwasher Is Not as Sterile as You ThinkHealth Tip: Recognize Symptoms of Food PoisoningOld Age Alone Not to Blame for Surgical ComplicationsAsthma in America Carries $82 Billion Price TagPsoriasis Is Independent Risk Factor for Comorbidity in ChildrenCore Muscle Weakness Increases Spinal Loading, Back InjuriesFDA Bans Use of Opioid-Containing Cough Meds by KidsCan Deportation Fears Hurt the Heart?Health Tip: Maintain Brain Health'Bone Cement': A Non-Surgical Option for Painful Joints?Some Patients Would Choose Antibiotics for AppendicitisStudy Gets to the Core of Back Pain in RunnersComplete Handover of Anesthesia Care May Up ComplicationsSchool-Based Telemedicine Asthma Management Is EffectiveProvider Counseling of Exercise for Arthritis Patients ImprovedSurgery or Antibiotics for Appendicitis? Here's What Patients ChoseIs Surgery Riskier for Black Children?Vitamin D Supplements May Make Arteries HealthierMental Disorders Common in Kids With Chronic Physical ConditionsWhat to Do if Your Child Has ChickenpoxPain Self-Efficacy Questionnaire Helps to Evaluate Migraine PainAdjuvanted Shingles Subunit Vaccine Likely More Cost-EffectiveSpike Seen in Kids' Eye Injuries From BB, Paintball GunsFor Poorer Americans, Stress Brings Worse HealthRespiratory Virus Lurks as Wintertime WorryHow to Get Your Health on Track for 2018Beware Carbon Monoxide Dangers When Cold Weather StrikesStatic Perimetry Approach May Be Better for Kids With GlaucomaMom-to-Be's Immune Response May Trigger Zika Birth DefectsHealth Tip: Avoid Kidney DiseaseClean Air Act May Be Saving More Lives Than ThoughtRacial/Ethnic Disparities Up for Live Donor Kidney TransplantScripted Callbacks Do Not Prevent 30-Day Returns of ER DischargesHealth Tip: Stay WellSerum Caffeine, Metabolites May Predict Early Parkinson's DiseaseHysterectomy May Have Long-Term Health RisksStem Cell Transplant Shows Promise for Immune Disorder SclerodermaCan Caffeine Levels in Blood Predict Parkinson's?New Hope for 'Ringing' in the EarsBroader Statin Use Improves Atherosclerotic CVD Prevention10 Percent of Heart Recipients Develop De Novo Malignancy
Questions and AnswersLinksBook Reviews
Related Topics

Cancer
Men's Health
Women's Health

Diabetes Drug Shows Promise Against Parkinson's

HealthDay News
by -- Robert Preidt
Updated: Aug 4th 2017

new article illustration

FRIDAY, Aug. 4, 2017 (HealthDay News) -- The diabetes drug exenatide (Byetta) may do double duty as a treatment for Parkinson's disease, a new study suggests.

"This is a very promising finding, as the drug holds potential to affect the course of the disease itself, and not merely the symptoms," said senior study author Tom Foltynie, from University College London's Institute of Neurology.

"With existing treatments, we can relieve most of the symptoms [of Parkinson's] for some years, but the disease continues to worsen," he said in a university news release. "This is the strongest evidence we have so far that a drug could do more than provide symptom relief for Parkinson's disease."

Parkinson's is the second most common neurodegenerative disease worldwide, the researchers noted. The condition results in muscle stiffness, slowed movement, tremors, sleep disturbance and chronic fatigue.

In the study, 60 people with Parkinson's received either a weekly injection of exenatide or an inactive placebo for 48 weeks, along with their regular medications.

At the end of that period, those who took the diabetes drug scored four points higher on a 132-point scale of agility, speech and tremors than those who took the placebo. The difference was statistically significant, the study authors said.

The findings were published Aug. 3 in the The Lancet.

According to Brian Fiske, senior vice president of research programs at The Michael J. Fox Foundation for Parkinson's Research, "Using approved therapies for one condition to treat another, or drug repurposing, offers new avenues to speed Parkinson's therapeutic development." The foundation funded the study.

"The results from the exenatide studies justify continued testing, but clinicians and patients are urged not to add exenatide to their regimens until more is known about their safety and impact on Parkinson's," Fiske said.

Another Parkinson's expert agreed that more research is in order.

"While these are exciting findings, the observed benefit was small and only in one outcome-measure," said Dr. Martin Niethammer, a neurologist at Northwell Health's Neuroscience Institute, in Manhasset, N.Y.

"This might relate to the study being relatively small and of short duration, rather than lack of efficacy [effectiveness] of exenatide, and more study is certainly needed," he noted.

"This trial does provide an excellent rationale for larger and longer trials, and it remains to be seen if exenatide, and drugs like it, truly have a disease-modifying effect or merely improve the symptoms of Parkinson's disease," Niethammer said.

More information

The U.S. National Institute of Neurological Disorders and Stroke has more on Parkinson's disease.